
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery”, Eur Urol, vol. 45, pp. 620-6; discussion 626-7, 2004.
, ,
“Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 66-78, 2016.
, “How do symptoms indicative of BPH progress in real life practice? The UK experience”, Eur Urol, vol. 38 Suppl 1, pp. 48-53, 2000.
, “Incidence, prevalence and management of lower urinary tract symptoms in men in the UK”, BJU Int, vol. 95, pp. 557-62, 2005.
, “Influenza-attributable burden in United Kingdom primary care”, Epidemiol Infect, vol. 144, pp. 537-47, 2016.
, “Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK”, BMJ Open, vol. 6, p. e009337, 2016.
, “Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom”, BMC Infect Dis, vol. 15, p. 443, 2015.
, “No risk of drug-associated liver injury with alpha1-adrenoreceptor blocking agents in men with BPH: results from an observational study using the GPRD”, Pharmacoepidemiol Drug Saf, vol. 14, pp. 75-80, 2005.
, “Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis”, Diabetes Ther, vol. 7, pp. 105-24, 2016.
, “Patterns of prescription of PC4 by general practitioners in England and Wales”, Eur J Contracept Reprod Health Care, vol. 5, pp. 241-7, 2000.
, “Repeated use of hormonal emergency contraception by younger women in the UK”, Br J Fam Plann, vol. 26, pp. 138-43, 2000.
, “Risk of cancer in patients exposed to gabapentin in two electronic medical record systems”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 214-25, 2012.
, “Risk of cataract among idiopathic thrombocytopenic purpura patients in the UK general practice research database”, Pharmacoepidemiol Drug Saf, vol. 18, pp. 380-5, 2009.
, ,